Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Pichler, Herbert
[Clear All Filters]
2019
Pichler H
,
Lawitschka A
,
Glogova E
,
Willasch AM
,
von Luettichau I
,
Lehrnbecher T
,
Matthes-Martin S
,
Lang P
,
Bader P
,
Sykora KW
, et al.
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia - A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP.
Am J Hematol. 2019.
PubMed
Google Scholar
Schiefer A-I
,
Salzer E
,
Füreder A
,
Szepfalusi Z
,
Müller-Sacherer T
,
Huber W-D
,
Michel-Behnke I
,
Lawitschka A
,
Pichler H
,
Mann G
, et al.
PD-L1 and PD1 expression in post-transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter- and intra-individual descriptive study covering the whole spectrum of PTLD categories.
Cancer Med. 2019.
PubMed
Google Scholar
2020
Willasch AManfred
,
Peters C
,
Sedlacek P
,
Dalle J-H
,
Kitra-Roussou V
,
Yeşilipek A
,
Wachowiak J
,
Lankester A
,
Prete A
,
Hamidieh AAli
, et al.
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study.
Bone Marrow Transplant. 2020.
PubMed
Google Scholar
Debiasi M
,
Pichler H
,
Klinglmüller F
,
Boztug H
,
Schmidthaler K
,
Rech J
,
Scherer D
,
Lupinek C
,
Valenta R
,
Kacinska-Pfaller E
, et al.
Transfer and loss of allergen-specific responses via stem cell transplantation: a prospective observational study.
Allergy. 2020.
PubMed
Google Scholar
2021
Obrová K
,
Grumaz S
,
Remely M
,
Czurda S
,
Krickl I
,
Herndlhofer S
,
Gleixner KV
,
Sperr WR
,
Größlinger L
,
Frank T
, et al.
Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasms.
Am J Hematol. 2021.
PubMed
Google Scholar
2023
Bader P
,
Poetschger U
,
Dalle J-H
,
Moser LM
,
Balduzzi ACristina
,
Ansari M
,
Buechner J
,
Güngör T
,
Ifversen M
,
Kriván G
, et al.
Low rate of nonrelapse mortality in under 4-year-olds with ALL given chemo-conditioning for HSCT: Phase III FORUM study.
Blood Adv. 2023.
PubMed
Google Scholar
2024
Averbuch D
,
Tridello G
,
Wendel L
,
Itälä-Remes M
,
Oren I
,
Karas M
,
Blijlevens N
,
Beguin Y
,
Broers A
,
Calore E
, et al.
Listeria monocytogenes infections in hematopoietic cell transplant recipients: clinical manifestations and risk factors: A multinational retrospective case control study of the Infectious Diseases Working Party (IDWP) of the European Society for Blood and
. Transplant Cell Ther. 2024.
PubMed
Google Scholar